NCT00076817View on ClinicalTrials.gov

Safety and Effectiveness of Administering an HIV Vaccine in the Groin Versus the Arm

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2008

Conditions
HIV InfectionsHIV Seronegativity
Interventions
BIOLOGICAL

ALVAC-HIV (vCP205)

Canarypox virus vector vaccine

BIOLOGICAL

ALVAC-HIV (vCP205)

Canarypox virus vector vaccine placbo

Trial Locations (1)

90095-7019

UCLA Center for HIV and Digestive Diseases, Los Angeles

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00076817 - Safety and Effectiveness of Administering an HIV Vaccine in the Groin Versus the Arm | Biotech Hunter | Biotech Hunter